Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-000863
Filing Date
2025-02-11
Accepted
2025-02-11 11:05:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2949
  Complete submission text file 0001959173-25-000863.txt   4363
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Subject) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-19319 | Film No.: 25608218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Tatsis Ourania (Reporting) CIK: 0001789815 (see all company filings)

Type: 144